COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab

Annette Bruchfeld; Andreas Kronbichler; Federico Alberici; Fernando C Fervenza; David R W Jayne; Mårten Segelmark; Vladimir Tesar; Wladimir M Szpirt

doi:10.1093/ndt/gfab174

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab

Annette Bruchfeld, Andreas Kronbichler, Federico Alberici, Fernando C Fervenza, David R W Jayne, Mårten Segelmark, Vladimir Tesar, Wladimir M Szpirt

12 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Vol/bind	36
Udgave nummer	9
Sider (fra-til)	1758-1760
Antal sider	3
ISSN	0931-0509
DOI	https://doi.org/10.1093/ndt/gfab174
Status	Udgivet - 27 aug. 2021

Adgang til dokumentet

10.1093/ndt/gfab174

Andre filer og links

Link to publication in Scopus

Citationsformater

Bruchfeld, A., Kronbichler, A., Alberici, F., Fervenza, F. C., Jayne, D. R. W., Segelmark, M., Tesar, V., & Szpirt, W. M. (2021). COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36(9), 1758-1760. https://doi.org/10.1093/ndt/gfab174

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. / Bruchfeld, Annette; Kronbichler, Andreas; Alberici, Federico et al.
I: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Bind 36, Nr. 9, 27.08.2021, s. 1758-1760.

Publikation: Bidrag til tidsskrift › Letter › peer review

Bruchfeld, A, Kronbichler, A, Alberici, F, Fervenza, FC, Jayne, DRW, Segelmark, M, Tesar, V & Szpirt, WM 2021, 'COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, bind 36, nr. 9, s. 1758-1760. https://doi.org/10.1093/ndt/gfab174

Bruchfeld A, Kronbichler A, Alberici F, Fervenza FC, Jayne DRW, Segelmark M et al. COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 aug. 27;36(9):1758-1760. doi: 10.1093/ndt/gfab174

@article{ce451188dbf447ac9e8f708632ff80c0,

title = "COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab",

keywords = "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy, Antibodies, Antineutrophil Cytoplasmic, COVID-19/prevention & control, COVID-19 Vaccines, Humans, Immunologic Factors, Remission Induction, Rituximab/therapeutic use",

author = "Annette Bruchfeld and Andreas Kronbichler and Federico Alberici and Fervenza, {Fernando C} and Jayne, {David R W} and M{\aa}rten Segelmark and Vladimir Tesar and Szpirt, {Wladimir M}",

year = "2021",

month = aug,

day = "27",

doi = "10.1093/ndt/gfab174",

language = "English",

volume = "36",

pages = "1758--1760",

journal = "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",

issn = "0931-0509",

publisher = "OXFORD UNIV PRESS",

number = "9",

}

TY - JOUR

T1 - COVID-19 and ANCA-associated vasculitis

T2 - recommendations for vaccine preparedness and the use of rituximab

AU - Bruchfeld, Annette

AU - Kronbichler, Andreas

AU - Alberici, Federico

AU - Fervenza, Fernando C

AU - Jayne, David R W

AU - Segelmark, Mårten

AU - Tesar, Vladimir

AU - Szpirt, Wladimir M

PY - 2021/8/27

Y1 - 2021/8/27

KW - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy

KW - Antibodies, Antineutrophil Cytoplasmic

KW - COVID-19/prevention & control

KW - COVID-19 Vaccines

KW - Humans

KW - Immunologic Factors

KW - Remission Induction

KW - Rituximab/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=85113466049&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfab174

DO - 10.1093/ndt/gfab174

M3 - Letter

C2 - 33944946

SN - 0931-0509

VL - 36

SP - 1758

EP - 1760

JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

IS - 9

ER -